HOME >> MEDICINE >> NEWS
'Rhythm method' may kill off more embryos than other methods of contraception

The "rhythm method" may kill off more embryos than other contraceptive methods, such as coils, morning after pills, and oral contraceptives, suggests an article in the Journal of Medical Ethics.

The method relies on abstinence during the most fertile period of a woman's menstrual cycle. For a woman who has regular 28 day cycles, this is around days 10 to 17 of the cycle.

It is the only method of birth control condoned by the Catholic Church, because it doesn't interfere with conception, so allowing nature to take its course.

It is believed that the method works because it prevents conception from occurring. But says Professor Bovens, it may owe much of its success to the fact that embryos conceived on the fringes of the fertile period are less viable than those conceived towards the middle.

We don't know how much lower embryo viability is outside this fertile period, contends Professor Bovens, but we can calculate that two to three embryos will have died every time the rhythm method results in a pregnancy.

Is it not just as callous to organise your sex life to make it harder for a fertilised egg to survive, using this method, as it is to use the coil or the morning after pill, he asks?

Professor Bovens cites Randy Alcorn, a US pro-life campaigner, who has equated global oral contraceptive use to chemical abortion that is responsible for tens of thousands of deaths of embryos, or unborn children, every year.

But says Professor Bovens: if all oral contraceptive users converted to the rhythm method, then they would be effectively causing the deaths of millions of embryos.

Similarly, regular condom users, whose choice of contraception is deemed to be 95% effective in preventing pregnancy, would "cause less embryonic deaths than the rhythm method," he says.

"the rhythm method may well be responsible for massive embryonic death, and the same logic that turned pro-lifers away from morning after pills,
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ Specialty Journals
24-May-2006


Page: 1 2

Related medicine news :

1. DNA repair in mammal embryos is a matter of timing
2. Chemotherapy with bevacizumab increases risk of blood clots in arteries
3. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
4. Borderline personality disorder shows improvements with intensive psychotherapy
5. UK and other European countries should introduce universal childhood hepatitis B vaccination
6. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
7. Chemotherapy may enhance the effectiveness of brain tumor vaccines
8. Brain-boosting pill alleviates post-chemotherapy fogginess
9. Adding radioimmunotherapy to chemo may help patients with lymphoma
10. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
11. Medical management of another condition may not lead to early cancer diagnosis

Post Your Comments:
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... its Board of Directors. Hal B. Jenson, M.D., ... of Medicine, has been named President. Maria C. ... of California San Diego, is the President-Designate, and Glenn ... Medical Center, is the Secretary-Treasurer. Kenneth B. Simons, ...
(Date:5/21/2013)... Dr. James C. Wittig, Chief of ... Sarcoma Division of the John Theurer Cancer Center at ... named one of the top 13 Orthopedic Oncologists in ... Wittig is one of approximately 125 surgeons in America ... by surveying thought leaders in the field of Oncology. ...
(Date:5/21/2013)... 21, 2013 Brunswick Laboratories, Inc. ... the development and standardization of validated analytical methods, ... Brunswick Laboratories and the USDA, as a First ... This decision comes after extensive review by an ... Harnly of the U.S. Department of Agriculture. , ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3
(Date:5/21/2013)... 2013 Ceregene, Inc. today announced additional ... double-blind, randomized, controlled Phase 2b clinical study of ... designed to deliver the neurotrophic factor neurturin, for ... robust response to CERE-120 in Parkinson,s patients diagnosed ... those diagnosed 10 years or more (p<.005), as ...
(Date:5/20/2013)... , May 21, 2013 ... Assembly, where world,s health ministers gather to address the ... Mental and neurological disorders (MNDs) affect 700 million ... non-communicable disease (NCD) burden ,Do You Mind?, ... the role each can play to collectively address MNDs ...
(Date:5/20/2013)... May 20, 2013 The Board of ... companies include OMNIlife science®, Inc., Enztec, Ltd., and Praxim, ... Board.  Guy Mayer , an ... of the Board of Directors and David Johnson, an ... director. Before joining OSI as Board ...
Breaking Medicine Technology:Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3
Cached News: